Fig. 1

Recruitment process of the present study. nCRT, neoadjuvant chemoradiotherapy; LARC, locally advanced rectal cancer; ADC, apparent diffusion coefficient; T1c, T1 contrast-enhanced; T2w, T2 weighted
Recruitment process of the present study. nCRT, neoadjuvant chemoradiotherapy; LARC, locally advanced rectal cancer; ADC, apparent diffusion coefficient; T1c, T1 contrast-enhanced; T2w, T2 weighted